Vidarabine Monophosphate

Tier C — Watch / trade

Originator

1997

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：Not applicable

Indications (approved)：巨细胞病毒感染, Herpesvirus infection

Regional status

China

Approved

1997-01-01

Japan

Factories producing this API8

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

8 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates6 routes

Originator routes × 0Optimised (non-patent) × 6Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 2 · Total yield /

(I)70439-1-a3083-77-0(II)70439-1-a—(III)70439-1-a73-24-5API · Vidarabine Monophosphate

Code	CAS No.	Intermediate
(I)70439-1-a	3083-77-0	1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
(II)70439-1-a	-	(1xi)-1,4-Anhydro-1-phosphono-D-arabinitol
(III)70439-1-a	73-24-5	6-Aminopurine

OptimisedRoute 2Steps 3 · Total yield /

(I)70439-2-a58-61-7(IIa)70439-2-a132887-08-2(IIb)70439-2-a2171494-38-3(III)70439-2-a65174-95-0API · Vidarabine Monophosphate

Code	CAS No.	Intermediate
(I)70439-2-a	58-61-7 Available	(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(IIa)70439-2-a	132887-08-2	2'-O-(4-Nitrobenzene-1-sulfonyl)adenosine
(IIb)70439-2-a	2171494-38-3	2'-O-(3,5-Dinitrobenzene-1-sulfonyl)adenosine
(III)70439-2-a	65174-95-0	9-(2-O-Acetyl-beta-D-arabinofuranosyl)-9H-purin-6-amine

OptimisedRoute 3Steps 2 · Total yield /

(I)70439-3-a—(II)70439-3-a—API · Vidarabine Monophosphate

Code	CAS No.	Intermediate
(I)70439-3-a	-	6-Amino-9-[3,5-di-O-acetyl-2-O-(4-methylbenzene-1-sulfonyl)-beta-D-arabinofuranosyl]-7,9-dihydro-8H-purin-8-one
(II)70439-3-a	-	(8Z)-9-beta-D-Arabinofuranosyl-8-hydrazinylidene-8,9-dihydro-7H-purin-6-amine

OptimisedRoute 4Steps 1 · Total yield /

(I)70439-4-a5746-27-0API · Vidarabine Monophosphate

Code	CAS No.	Intermediate
(I)70439-4-a	5746-27-0	N6-Aminoadenosine

OptimisedRoute 5Steps 1 · Total yield /

(I)70439-5-a73-24-5(II)70439-5-a—API · Vidarabine Monophosphate

Code	CAS No.	Intermediate
(I)70439-5-a	73-24-5	6-Aminopurine
(II)70439-5-a	-	[(2R,3S,4S,5R)-3,4,5,6-Tetrahydroxyoxan-2-yl]methyl phosphate

OptimisedRoute 6Steps 1 · Total yield /

(I)229059-10-a66-22-8(II)229059-10-a—(III)229059-10-a3083-77-0API · Vidarabine Monophosphate

Code	CAS No.	Intermediate
(I)229059-10-a	66-22-8	1,2,3,4-Tetrahydropyrimidine-2,4-dione
(II)229059-10-a	-	[(2R,3S,4S,5R)-3,4,5,6-Tetrahydroxyoxan-2-yl]methyl phosphate
(III)229059-10-a	3083-77-0	1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

Frequently asked questions

What are the approved indications of Vidarabine Monophosphate?

Approved indications include: 巨细胞病毒感染, Herpesvirus infection.

When does the Vidarabine Monophosphate patent expire?

No public expiry year is available for Vidarabine Monophosphate yet; this page updates once verified.

How many synthesis routes are recorded for Vidarabine Monophosphate?

6 synthesis routes are recorded; the shortest is 1 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Vidarabine Monophosphate intermediates?

1 intermediate CAS of Vidarabine Monophosphate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Vidarabine Monophosphate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27